NCT01822210View on ClinicalTrials.gov

Botulinum Toxin for Stomach Cancer Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Stomach Neoplasms
Interventions
DRUG

Botox

injection by gastroscopy (100 Allergen units)

Trial Locations (1)

Unknown

Department of Gastrointestinal Surgery, St Olavs Hospital Trondheim University Hospital, Trondheim

All Listed Sponsors
collaborator

Norwegian University of Science and Technology

OTHER

lead

St. Olavs Hospital

OTHER

NCT01822210 - Botulinum Toxin for Stomach Cancer Treatment | Biotech Hunter | Biotech Hunter